The novel alpha2-adrenoceptor agonist [3H]mivazerol binds to non-adrenergic binding sites in human striatum membranes that are distinct from imidazoline receptors

Neurochemistry International

Volumn 31, Issue 1, 1997, Pages 125-129

  Flamez, A ^a   Gillard, M ^b   De Backer, J P ^a   Vauquelin, G ^a   Noyer, M ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DEXMEDETOMIDINE; IDAZOXAN; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE RECEPTOR; MIVAZOROL; RAUWOLSCINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; HUMAN; HUMAN TISSUE; MEMBRANE; PRIORITY JOURNAL;

ADRENERGIC ALPHA-AGONISTS; AGED; CLONIDINE; CORPUS STRIATUM; FEMALE; HUMANS; IDAZOXAN; IMIDAZOLES; MALE; MEMBRANES; MIDDLE AGED; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; TRITIUM;

EID: 0031011595     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00117-9     Document Type: Article

References (19)

1. 3H]idazoxan binding sites (NAIBS) in postmortem brains of suicide victims. Fundam. Clin. Pharmacol. 6(57), P27.
2. Bousquet, P. and Schwartz, J. (1983) α-Adrenergic drugs. Pharmacological tools for the study of the central vasomotor control. Biochem. Pharmacol. 32, 1459-1465.
3. Bricca, G., Dontonwill, M., Molines, A., Feldman, J., Tibirica, E., Belcourt, A. and Bousquet, P. (1989) Rilmenidine selectivity for imidazoline receptors in human brain. Eur. J. Pharmacol. 163, 373-377.
4. 2-adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes. Biochem. Pharmacol. 38, 455-463.
5. 1A receptors in human cerebral cortex. Eur. J. Pharmacol. 159, 307-310.
6. 2-adrenoceptors in the human central nervous system. Neuroscience 59, 589-598.
7. 2 subtypes. Fundam. Clin. Pharmacol. 6(55), P18.
8. 1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20 (Suppl. 4), S1-S10.
9. 2-adrenergic receptor subtypes stably expressed in CHO cells. 10th Camerino-Noordwijkerhout Symposium - Perspective in Receptor Research, p. 42.
10. 3H]rilmenidine in membranes from rat cerebral cortex. Eur. J. Pharmacol. 218, 101-108.
11. 2-adrenergic drugs also bind with high affinity to a non-adrenergic site. Molec. Pharmacol. 35, 324-330.
12. 2-adrenergic receptors: binding studies on different human and rat membrane preparations. Neurochem. Int. 24, 221-229.
13. 2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease. Neurosci. Lett. 160, 109-112.
14. 2-with monoamine oxidase-B sites. J. Neurochem. 61, 881-889.
15. 3H]clonidine. Br. J. Pharmacol. 116, 439P.
16. 3H]atipamezol in S115 cells. Can. J. Physiol. Pharmacol. 72, 324.
17. 2 imidazoline binding sites on monoamine oxidases. J. biol. Chem. 270, 9856-9861.
18. Tibiriça, E., Feldman, J., Mermet, C., Monassier, L., Gonon, F. and Bousquet, P. (1991) Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-prefering receptors. Eur. J. Pharmacol. 209, 213-221.
19. Weiland, G. A. and Molinoff, P. B. (1981) Quantitative analysis of drug receptor-interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 29, 313-330.